The use of mifepristone in the treatment of neuropsychiatric disorders TRENDS IN ENDOCRINOLOGY AND METABOLISM DeBattista, C., Belanoff, J. 2006; 17 (3): 117-121

Abstract

Mifepristone is a potent glucocorticoid and progesterone receptor antagonist. The pathophysiology of a number of neuropsychiatric disorders implicates abnormalities in glucocorticoid function. These include mood disorders such as psychotic major depression and bipolar depression. In addition, cognitive disorders such as Alzheimer's disease might also be partially mediated by abnormalities in the hypothalamic-pituitary-adrenal axis. Preliminary studies suggest that mifepristone might have a role in the treatment of a number of neuropsychiatric disorders.

View details for DOI 10.1016/j.tem.2006.02.006

View details for Web of Science ID 000237145300007

View details for PubMedID 16530421